Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Vliianie fitogemaggliutinina, mitogena lakonosa i syvorotki krovi na klonirovanie krovetvornykh kletok in vitro v norme i pri leǐkozakh. / Kulibaba, T. G.
в: Eksperimentalnaa onkologia, Том 7, № 1, 1985, стр. 42-45.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Vliianie fitogemaggliutinina, mitogena lakonosa i syvorotki krovi na klonirovanie krovetvornykh kletok in vitro v norme i pri leǐkozakh.
AU - Kulibaba, T. G.
PY - 1985
Y1 - 1985
N2 - Culture of normal and leukemic hemopoietic cells was performed in the "agar drop-liquid medium" system. It is shown that cloning of the hemopoietic cells with mitogen does not result in amplication of proliferation of clonal cells, and does not enchance formation of optimal conditions for cell growth in vitro. Addition of blood serum of healthy people, and especially the serum of patients with different hematologic diseases to the liquid medium, leads to an increase in CFU-GM or colonies. It is suggested that mitogens may exert an indirect action on the clonogenic cells in which a colony stimulating serum factor probably takes part.
AB - Culture of normal and leukemic hemopoietic cells was performed in the "agar drop-liquid medium" system. It is shown that cloning of the hemopoietic cells with mitogen does not result in amplication of proliferation of clonal cells, and does not enchance formation of optimal conditions for cell growth in vitro. Addition of blood serum of healthy people, and especially the serum of patients with different hematologic diseases to the liquid medium, leads to an increase in CFU-GM or colonies. It is suggested that mitogens may exert an indirect action on the clonogenic cells in which a colony stimulating serum factor probably takes part.
UR - http://www.scopus.com/inward/record.url?scp=0021975739&partnerID=8YFLogxK
M3 - статья
C2 - 3979339
AN - SCOPUS:0021975739
VL - 7
SP - 42
EP - 45
JO - Experimental Oncology
JF - Experimental Oncology
SN - 0204-3564
IS - 1
ER -
ID: 87442881